These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 7618547)

  • 1. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization.
    Chung JW; Park JH; Han JK; Choi BI; Han MC
    AJR Am J Roentgenol; 1995 Aug; 165(2):315-21. PubMed ID: 7618547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors.
    Uraki J; Yamakado K; Nakatsuka A; Takeda K
    Eur J Radiol; 2004 Jul; 51(1):12-8. PubMed ID: 15186879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors.
    Chern MC; Chuang VP; Liang CT; Lin ZH; Kuo TM
    J Vasc Interv Radiol; 2014 Jan; 25(1):32-40. PubMed ID: 24290099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
    J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter oily chemoembolization for the treatment of large hepatocellular carcinoma with an accompanying tumor thrombus in the right main branch of the portal vein and arterioportal shunting: report of one patient still surviving after more than seven years.
    Inoue K; Akaji H; Nakamura H
    Radiat Med; 1991; 9(3):105-7. PubMed ID: 1656485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Segmental arterio-portal chemo-embolization in hepatocellular carcinoma (cement therapy)].
    Oi H; Yamamoto T; Sawai Y; Fujino M; Okamura J; Nakamura H
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2853-7. PubMed ID: 2551228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Limitation of oily chemoembolization against hepatocellular carcinoma and arterioportal segmental chemoembolization].
    Nakamura H; Hashimoto T; Fujita M; Oi H; Inoue K; Mizumoto S; Sawada S; Takayasu Y; Hori S; Furui S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2849-52. PubMed ID: 2551227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
    Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates.
    Takayasu K; Muramatsu Y; Maeda T; Iwata R; Furukawa H; Muramatsu Y; Moriyama N; Okusaka T; Okada S; Ueno H
    AJR Am J Roentgenol; 2001 Mar; 176(3):681-8. PubMed ID: 11222205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein.
    Lee JH; Won JH; Park SI; Won JY; Lee DY; Kang BC
    J Vasc Interv Radiol; 2007 Mar; 18(3):377-82. PubMed ID: 17377183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
    J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role.
    Chung JW; Park JH; Han JK; Choi BI; Kim TK; Han MC
    J Vasc Interv Radiol; 1998; 9(3):495-500. PubMed ID: 9618112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB; Wang JH; Yan ZP; Qian S; Liu R
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma.
    Takayasu K; Arii S; Matsuo N; Yoshikawa M; Ryu M; Takasaki K; Sato M; Yamanaka N; Shimamura Y; Ohto M
    AJR Am J Roentgenol; 2000 Sep; 175(3):699-704. PubMed ID: 10954453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
    Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
    World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stage III, IV hepatocellular carcinoma patients surviving more than five years after transcatheter chemoembolization].
    Nakamura H; Mitani T; Murakami T; Hashimoto T; Nakanishi K; Maeshima S; Tsuda K; Tomoda K; Hori S; Kozuka T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1756-8. PubMed ID: 1326925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
    El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
    Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.